Choroidal Thickness in Ocular Sarcoidosis during Quiescent Phase Using Enhanced Depth Imaging Optical Coherence Tomography

dc.contributor.authorGungor, Sirel Gur
dc.contributor.authorAkkoyun, Imren
dc.contributor.authorReyhan, Nihan Haberal
dc.contributor.authorYesilirmak, Nilufer
dc.contributor.authorYilmaz, Gursel
dc.contributor.orcIDhttps://orcid.org/0000-0001-6178-8362en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-2860-7424en_US
dc.contributor.orcIDhttps://orcid.org/0000-0001-9852-9911en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-8632-2873en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-2589-7294en_US
dc.contributor.pubmedID24912003en_US
dc.contributor.researcherIDAAD-5967-2021en_US
dc.contributor.researcherIDAAK-7713-2021en_US
dc.contributor.researcherIDAAK-4587-2021en_US
dc.contributor.researcherIDAAD-7299-2020en_US
dc.contributor.researcherIDAAK-6987-2021en_US
dc.date.accessioned2024-01-29T12:50:39Z
dc.date.available2024-01-29T12:50:39Z
dc.date.issued2014
dc.description.abstractPurpose: To evaluate the choroidal thickness in patients with ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography (EDI-OCT) and comparing it with normal subjects. Method: Eighteen eyes of 9 patients with ocular sarcoidosis (8 women, 1 man, mean age: 59.12 +/- 18.49 years) were enrolled in this study. Their subfoveal choroidal thickness was measured using EDI-OCT in the quiescent phase of uveitis, and compared with the age-, sex-, and spherical equivalent-matched normal subjects (6 women, 3 men, mean age: 59.6 +/- 14.22 years). Results: The mean subfoveal choroidal thickness was 281.76 +/- 88.1 mm in patients with sarcoidosis and 342.32 +/- 71.02 mm in controls. Significant differences were found at points between nasal 1500 mm and temporal 1000 mm to the fovea between patients and control group (p = 0.002, at fovea). Conclusions: Patients with ocular sarcoidosis had thinner choroids in the quiescent phases when compared to normal subjects.en_US
dc.identifier.endpage293en_US
dc.identifier.issn0927-3948en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84904277576en_US
dc.identifier.startpage287en_US
dc.identifier.urihttp://hdl.handle.net/11727/11355
dc.identifier.volume22en_US
dc.identifier.wos000339806300007en_US
dc.language.isoengen_US
dc.relation.isversionof10.3109/09273948.2014.920034en_US
dc.relation.journalOCULAR IMMUNOLOGY AND INFLAMMATIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChoroidal thicknessen_US
dc.subjectenhanced depth imaging optical coherence tomographyen_US
dc.subjectquiescent phaseen_US
dc.subjectsarcoidosisen_US
dc.subjectuveitisen_US
dc.titleChoroidal Thickness in Ocular Sarcoidosis during Quiescent Phase Using Enhanced Depth Imaging Optical Coherence Tomographyen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: